November 7, 2022

Bio-Labs is now on Shopify

We are proud to announce our recent launch of the Shopify website, our consumer health division products are just a click away.
November 7, 2022

Bio-Labs is now on Shopify

We are proud to announce our recent launch of the Shopify website, our consumer health division products are just a click away.
August 19, 2022

Bio-Labs receives Best Pharmaceutical Entity Award 2022

Bio-Labs is proud to have received the “Best Pharmaceutical Entity 2022” award at the Rawalpindi Chamber of Commerce & Industry’s Annual Achievement Awards held in Bangkok on August 19, 2022 presented by the Thailand Deputy Prime Minister’s office. Our pursuit for excellence in pharmaceuticals shall continue with the same zeal and spirit going forward.
June 14, 2022

Bio-Labs Signed MOU with N-ovative Health Technologies (NHT), for cardiac stents & catheters

Bio-Labs (Pvt.) Ltd is proud and excited to sign the Memorandum of Understanding with N-ovative Health Technologies (NHT), an initiative of NUST, to bring its unique and advanced cardiac stents & catheters to the international markets.
June 7, 2022

Bio-Labs – Donated medicines to Sri Lanka

In lieu of the severe drug shortages in Sri Lanka owing to the ongoing economic crisis, Bio-Labs was heart in hands to provide relief to the Sri Lankan brothers and sisters when reached out to by the Srilanka High commission Islamabad.
February 14, 2022

Bio-Labs successfully launched Qualey (Quetiapine Fumarate) in it’s Psychiatry Division

Bio-Labs added a new product to the psychiatry division, Qualey (Quetiapine Fumarate). Bio-Labs is pleased and honored to help people take a step “Towards the Peak of Stability” through this product.
February 8, 2022

Bio-Labs Presents Most Effective, FDA Approved Combo for Covid-19 “Bioxovid” – (Nirmatrelvir + Ritonavir)

After the landmark success of (Remdesivir),(Favipiravir) & (Molnupiravir) in our fight against covid-19, Bio-Labs once again proves its solid stance by the launch of FDA approved oral treatment to effectively lower the Viral load of SARS-Cov-2 and other associated symptoms.
January 18, 2022

Ambassador of Azerbaijan H.E. Khazar Farhadov visits the manufacturing plant of Bio-Labs

Mr. Khazar Farhadov during a delegation visit to the manufacturing facility of Bio-Labs in Islamabad.
January 8, 2022

Bio-Labs Has Successfully Launched another Prime Life-Saving Drug: Merobio (Meropenem)

Reliving the commitment and mission, Bio-Labs added a new product to its inventory. Bio-Labs is both gratified and proud to launch Merobio (Meropenem) recently with one and only aim that is VALUING LIFE.
December 15, 2021

MOLNUCAP Capsules (Molnupiravir) breakthrough new drug for COVID-19

Bio-Labs is proud to be the first pharmaceutical company in Pakistan
November 23, 2021

Bio-Labs received the “Leading Pandemic Healthcare & Pharmaceutical Company Award”

Bio-Labs is honored to receive the “Leading Pandemic Healthcare & Pharmaceutical Company Award”
November 23, 2021

Bio-Labs Signed Several MOUs with Leading Sri Lankan Pharmaceutical Entities for Joint Ventures

Bio-Labs Signed Several MOUs with Leading Sri Lankan Pharmaceutical Entities for Joint Ventures
October 4, 2021

Bio-Labs Launched The Most Advanced, Rapid and Safe Bio-Maltose (Ferric carboxymaltose)

As the prevalence of Iron deficiency Anemia is on the all-time high, there is a need of a Rapid and safe way to replenish Serum Iron especially in pregnant females.
September 29, 2021

Bio-Labs Received “The Leading Pharmaceutical Exporter Award”

Islamabad: Bio-Labs has Received "The Leading Pharmaceutical Exporter Award"
September 28, 2021

The Courtyard Café

Bio-Labs is proud to present the newest of its CSR Projects-“The Courtyard Café ”
August 14, 2021

Bio-Labs launches Biozodex (Dexlansoprazole)

A revolutionary development that controls symptoms of gastroesophageal reflux disease and cares for all digestive and stomach issues.
January 12, 2021

Introducing FDA-Approved ZH Hand Sanitizer Gel

ZH Therapeutics is also the sole pharma company from Pakistan authorized to produce ZH Hand Sanitizer. It’s another great honor for everyone associated by ZH Therapeutics and Bio-Labs.

November 4, 2020

Another feather in Bio-Labs’ cap

As part of its commitment to sustainable living and building a healthier Pakistan, Team Bio-Labs organized a Saplings Plantation Event at Gulistan-e-Fatima Park in E-7, Islamabad on October 19, 2020.

September 9, 2020

RIVONA (Remdesivir) Leading the Fight Against COVID-19

Proud to have launched RIVONA (Remdesivir) injection for treatment of COVID-19 patients in Pakistan and around the globe. Bio-Labs is a pioneer in introducing the breakthrough treatment not only in Pakistan but globally as well. RIVONA is available for export to international markets as well. For queries, please email: [email protected], [email protected]

June 15, 2020

COVID-19 Breakthrough Treatment

As a pioneer in Pakistan, Bio-Labs will start production this month of the antiviral drug Remdesivir, which has shown promise in fighting COVID 19 and has recently been approved by US FDA for the respiratory disease caused by the coronavirus.

May 15, 2020

Advanced SaniteX Hand Sanitizer Liquid & Gel

Bio-Labs is proud to have introduced SANITEX to help our nation fight COVID. The hand sanitizer has been made following WHO standards and is available nation wide..

March 25, 2019

New therapeutic products launches – Mar 2019

New therapeutic products launched including MyVan injection (Vancomycin), Life Tablets (Leflunomide) and P-Trand tablets (Tramadol+Paracetamol)
March 11, 2019

Oncology and Breast Cancer Products Launches – March 2019

Bio-Labs continues to bring innovative therapeutic solutions in the field of Oncology and Breast Cancer through launch of Letfer Tablets (Letrozole)
February 20, 2019

PPB (Kenya) GMP Certificate Re-Issuance – FEB 2019

Pharmacy and Poison Board, Kenya (PPB) successfully culminated audit of Bio-Labs manufacturing facility for re-issuance of Good Manufacturing Practices (GMP) certificate.
January 10, 2019

Skincare/Dermatology New Product Launches –Jan 2019

Proudly launching new products in the field of Skincare/Dermatology. C-Mycin cream (Clindamycin) , Bio Eflorin cream (Eflornithine) , Eslod tablets (Desloratadine) , Flucin cream (Fluocinolone Acetonide), and Flacet N cream (Fluocinolone/Neomycin).
January 15, 2018

New Product Launches – Jan 2018

Several new and novel lifesaving drugs are launched in the domestic and international markets including TIGABIO Injection ( Tigecycline USP ) and BIOROLAC Ampoule (Ketorolac Tromethamine) and BIOPRIM Injection (Cefepime HCl)
November 30, 2017

Bio-Labs achieve GMP compliance certificate from FDA Philippines, based on PIC/S guidelines

Achievement of GMP compliance certificate from FDA Philippines, based on PIC/S Guidelines
August 16, 2017

DRAP Approval of veterinary injectable facilities

Drug Regulatory Authority of Pakistan (DRAP) grants approval of veterinary injectable facilities including penicillin liquid, penicillin powder and general liquid injections for veterinary use.
May 20, 2017

Certificate for export of human therapeutic drugs to the Republic of Yemen

Ministry of Public Health & Population, Republic of Yemen successfully conducts a panel inspection of our manufacturing facility and grants GMP/Registration certificate for export of human therapeutic drugs to the Republic of Yemen
January 15, 2017

Penicillin Facility for Animal Health products

Bio-Labs establishes a dedicated penicillin facility for manufacturing of oral dosage forms for Animal Health products
October 25, 2016

RCCI International achievement award

Bio-Labs received another achievement milestone in form of an award by the Rawalpindi Chamber of Commerce...
March 2, 2016

Bio-labs expands international operations

Bio-Labs expands international operations into CIS countries by commencing regulatory registrations in several therapeutic categories.
December 10, 2015

Fusidic Acid, Betamethasone & Hydrocortisone.

A new range of dermatology products under the brand name of BUSID CREAM are launched including Fusidic Acid, Betamethasone & Hydrocortisone for better skin infections treatment.
October 12, 2015

Bio-Labs launches BIO-D3

Bio-Labs launches BIO-D3, a new range of Vitamin D3 products including dosage forms in liquid ampoules, tablets and drops...
May 12, 2015

Kenya Pharmacy & Poison Board (PPB)

Kenya Pharmacy & Poison Board (PPB) grants Good Manufacturing Practices license to Bio-Labs after successful plant inspection allowing further market expansion in the African continent.
June 5, 2014

New Products Launched

Bio-Labs recently launched several new products including liquid ampoules such as Iron Sucrose and Vitamin D3 (Cholecalciferol) being manufactured in its new manufacturing facility.
July 15, 2013

12th Fastest Growing Company in Arabia 500

Bio-Labs has recently received another accolade of being ranked number 12 in the fastest growing companies in the region known as ARABIA 500 by Harvard University […]
March 10, 2013

25th fastest growing company in Pakistan

Bio-Labs has the honor of being ranked 25th fastest growing company in Pakistan by Harvard Business School Michael Porter’s ALL WORLD NETWORK. For details, please visit: […]
February 15, 2013

Bio-Labs successfully implements SAP

Bio-Labs successfully implements SAP business management software technology integrating all core business...
March 5, 2012

New product launch – IROPAS

New product launch of IROPAS Chewable Tablets and Sugar Free Syrup (Iron Protein Succinylate)
October 2, 2011

Newly developed manufacturing facility

Newly developed manufacturing facility for production of sterile liquid ampoules, infusions, and lyophilized injections is approved by MOH, Pakistan
July 14, 2011

New Manufacturing facility

Newly renovated manufacturing facility for Cephalosporin Dry Powder Vial Injections commences production
March 10, 2011

Successful registration of several products

Successful registration of several products by international regulatory authorities in Vietnam, Philippines, Saudi Arabia and Afghanistan